Clinical Observation of Rabeprazole Combined with Moxibustion in the Treatment of Reflux Esophagitis

Ninety patients with reflux esophagitis admitted to our hospital from February 2012 to January 2014 were randomly divided into an observation group and a control group, with 45 patients in each group. The control group was treated with rabeprazole, while the observation group received moxibustion treatment in addition to the rabeprazole treatment. Clinical efficacy, endoscopic efficacy, and recurrence rate were compared between the two groups. Results showed that the clinical efficacy and endoscopic efficacy of the observation group were significantly better than those of the control group (P < 0.05), and the recurrence rate was significantly lower in the observation group (P < 0.05). Rabeprazole combined with moxibustion is significantly effective in treating reflux esophagitis with a low recurrence rate, and is worthy of clinical promotion and application.